J. Mattlener

Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors

K. Hekmat, M. Hallek, D. Kirsch, 2022, Journal for ImmunoTherapy of Cancer.

In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin's lymphoma and facilitates ultrasensitive residual disease detection.

A. Rosenwald, W. Klapper, A. Hagenbeek, 2021, Med.

Exhaustive circulating tumor DNA sequencing reveals the genomic landscape of Hodgkin lymphoma and facilitates ultrasensitive detection of minimal residual disease

A. Rosenwald, W. Klapper, A. Hagenbeek, 2021, medRxiv.

Clinical applications of circulating tumor DNA in Hodgkin lymphoma.

J. Ferdinandus, S. Borchmann, J. Heger, 2023, Seminars in hematology.

P037: High breadth whole exome sequencing of circulating tumor DNA identifies novel recurrent genetic alterations in Hodgkin lymphoma

J. Altmüller, P. Borchmann, A. Engert, 2022, HemaSphere.